Replicate Bioscience Announces Partnership with Novo Nordisk to Unlock Self-Replicating RNA Therapies for Obesity and Diabetes

Replicate Bioscience, a clinical-stage company pioneering self-replicating RNA technology today announced a multi-year research collaboration with Novo Nordisk.